AbbVie and Genmab Report Positive PFS Results from Phase 3 EPCORE® DLBCL-1 Trial of Epcoritamab in Relapsed/Refractory DLBCL

Based on the topline results from the EPCORE® DLBCL-1 trial, AbbVie along with partner Genmab will engage global regulatory authorities to discuss ...

January 19, 2026 | Monday | News
ElpasBio Partners With Fosun Kairos to Commercialize AlloJoin® Stem Cell Therapy for Knee Osteoarthritis in Greater China

ElpasBio Holdings ("ElpasBio"), a leading clinical-stage biotechnology company focused on regenerative medicine, announced that it has entered into a col...

January 15, 2026 | Thursday | News
IDT Relocates Bay Area Operations to Expanded Sunnyvale Innovation Hub

Genomics leader relocates to an expanded footprint in Sunnyvale New location enables customer continuity and provides increased innovation space to driv...

January 15, 2026 | Thursday | News
Cellistic Expands Echo™ Platform Portfolio With Three New GMP iPSC-Derived Cell Therapy Manufacturing Platforms

Cellistic, a global leader in allogeneic iPSC-derived cell therapy manufacturing, today announced the launch of three new iPSC-derived GMP cell therapy m...

January 15, 2026 | Thursday | News
Bridging the Biopharma Skills Gap: How Virtual Reality Is Training the Next Generation of Medicine Makers

As the UK races to secure its position as a global leader in advanced therapies, a growing skills gap threatens to undermine billions in investment and pat...

January 14, 2026 | Wednesday | Interview
Jubilant Biosys Opens Integrated Discovery and Scale-Up Facility to Meet Rising Global Biopharma Demand

 Jubilant Biosys Limited, a wholly owned subsidiary of Jubilant Pharmova Limited, and a global CRDMO operating from five sites across India ...

January 14, 2026 | Wednesday | News
TetraScience and Thermo Fisher Scientific Partner to Accelerate Scientific AI Across Biopharma R&D and Manufacturing

   TetraScience, the Scientific Data and AI company,  announced a collaboration with Thermo Fisher Scientific Inc., the world leader in ser...

January 14, 2026 | Wednesday | News
ChemWerth Appoints Chandrakanth Reddy as General Sales Manager in India

-ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengt...

January 13, 2026 | Tuesday | News
QIAGEN CEO Thierry Bernard Outlines 2026 Growth Priorities to Accelerate Path to $2 Billion in Pillar Sales by 2028

Building on strong momentum in 2025, new product launches and regulatory milestones planned for 2026 to support goal of at least $2 billion in combined...

January 13, 2026 | Tuesday | Company results
Aragen Launches CHOMax™ Platform to Accelerate Monoclonal Antibody Development from DNA to IND

Accelerated pathway: Integrated cell line development, process development, analytics, GMP drug substance, plus drug product support through quali...

January 12, 2026 | Monday | News
Codexis and Axolabs Partner to Evaluate Enzymatic RNA Manufacturing Platform

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing and Axolabs, part of LGC Gr...

January 12, 2026 | Monday | News
Sharp Sterile Advances Global Growth Strategy With $28M Lee Facility Expansion

Sharp Sterile Manufacturing has  announced a $28 million expansion of its site in Lee, Massachusetts. The enhanced state-of-the-art facility will st...

January 09, 2026 | Friday | News
HUTCHMED’s Sovleplenib Meets Primary Endpoint in Phase III ESLIM-02 Trial in wAIHA

— Delivers rapid, durable responses in wAIHA, the more common form of this potentially life-threatening disease —  HUTCHMED (China) Lim...

January 08, 2026 | Thursday | News
Lonza Licenses Clinically Validated ADC Platform to Sidewinder to Accelerate Bispecific Oncology Pipeline

  Multi-target license agreement grants Sidewinder access to Lonza's clinically validated ADC platform Sidewinder's ...

January 08, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close